Concepedia

Linda Ohrmund

LO

8

Publications

1.1K

Citations

8

H-Index

2009

Active since

Affiliations

Prometheus Biosciences (United States)(Current)

University of California San Diego

Mount Sinai Hospital

Robarts Clinical Trials

Western University

Linda Ohrmund is an author at Prometheus Biosciences (United States) specializing in medicine, autoimmunity, and autoimmune disease.

Top concepts

Publications per year

2009–2014

8

Publications

8

Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient

Niels Vande Casteele, Ann Gils, Sharat Singh et al. · The American Journal of Gastroenterology · 2013 · 342 citations

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Niels Vande Casteele, Reena Khanna, Barrett G. Levesque et al. · Gut · 2014 · 283 citations · Full text

Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum

Shui-Long Wang, Linda Ohrmund, Scott Hauenstein et al. · Journal of Immunological Methods · 2012 · 203 citations · Full text

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease

Barrett G. Levesque, Gordon R. Greenberg, Guangyong Zou et al. · Alimentary Pharmacology & Therapeutics · 2014 · 100 citations · Full text

Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay

Shui-Long Wang, Scott Hauenstein, Linda Ohrmund et al. · Journal of Pharmaceutical and Biomedical Analysis · 2013 · 80 citations · Full text

, , +23

Rows per page

1–5 of 8